Massive Bio Executives To Attend JPM Annual Healthcare Meeting

The 41st JPM Annual Healthcare Meeting will be held at The Westin St. Francis in San Francisco from January 9-12, 2023. Executives from Massive Bio will be in attendance.

Addressing today’s health and wellness challenges, the JPM Annual Healthcare Meeting will be held at The Westin St. Francis in San Francisco, California, from January 9-12, 2023. Every year, the JPM Annual Health Meeting gathers leaders in the healthcare industry to discuss how the latest developments, leading-edge research, and best practices can be applied to grow and scale digital health solutions. Speakers will share new ideas, strategies, and experiences for creating and implementing technologies that will reshape health and wellness.

More than 14,000 people from around the globe are expected to attend the 41st JPM Annual Healthcare Meeting, including executives from Massive Bio. Topics to be covered include digital health, artificial intelligence, deep learning, gene editing and bioengineering, mental health, implantable technology, wearable technology, m-Health, Telehealth and telemedicine, digitized self, behavioral science and psychology, finance and finance, startups and entrepreneurship, data analytics, preventive maintenance, personalized maintenance, service automation and collaboration.

Massive Bio has onboarded over 160,000+ cancer patients to find their clinical trial
See if you pre-qualify for clinical trials.

Our specialized team will contact you within 24 hours.

[EN] Blog Details - United States & Canada - English

Your Birthday



By filling out this form, you're consenting only to release your medical records. You're not agreeing to participate in clinical trials yet.

See if you pre-qualify for clinical trials.

Our specialized team will contact you within 24 hours.

[EN] Blog Details - United States & Canada - English

Your Birthday



By filling out this form, you're consenting only to release your medical records. You're not agreeing to participate in clinical trials yet.